SIMILAR PATTERNS OF AMINO ACIDS FOR 3M0W_E_P77E203
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gso | PROTEIN (GLYCINAMIDERIBONUCLEOTIDESYNTHETASE) (Escherichiacoli) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 4 | SER A 22PHE A 29LEU A 67ASP A 66 | None | 1.01A | 3m0wE-1gsoA:undetectable3m0wF-1gsoA:undetectable3m0wG-1gsoA:undetectable3m0wH-1gsoA:undetectable | 3m0wE-1gsoA:14.513m0wF-1gsoA:14.513m0wG-1gsoA:14.513m0wH-1gsoA:14.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1iay | 1-AMINOCYCLOPROPANE-1-CARBOXYLATESYNTHASE 2 (Solanumlycopersicum) |
PF00155(Aminotran_1_2) | 4 | PHE A 250SER A 252LEU A 204ASP A 237 | NoneNoneNonePLP A 500 (-3.5A) | 1.06A | 3m0wE-1iayA:undetectable3m0wF-1iayA:undetectable3m0wG-1iayA:undetectable3m0wH-1iayA:undetectable | 3m0wE-1iayA:11.033m0wF-1iayA:11.033m0wG-1iayA:11.033m0wH-1iayA:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jeq | KU70 (Homo sapiens) |
PF02037(SAP)PF02735(Ku)PF03730(Ku_C)PF03731(Ku_N) | 4 | SER A 236PHE A 40LEU A 202ASP A 201 | None | 0.93A | 3m0wE-1jeqA:undetectable3m0wF-1jeqA:undetectable3m0wG-1jeqA:undetectable3m0wH-1jeqA:undetectable | 3m0wE-1jeqA:10.673m0wF-1jeqA:10.673m0wG-1jeqA:10.673m0wH-1jeqA:10.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jpd | L-ALA-D/L-GLUEPIMERASE (Escherichiacoli) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | SER X 280CYH X 275LEU X 298ASP X 299 | None | 1.03A | 3m0wE-1jpdX:undetectable3m0wF-1jpdX:undetectable3m0wG-1jpdX:undetectable3m0wH-1jpdX:undetectable | 3m0wE-1jpdX:16.123m0wF-1jpdX:16.123m0wG-1jpdX:16.123m0wH-1jpdX:16.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1js6 | DOPA DECARBOXYLASE (Sus scrofa) |
PF00282(Pyridoxal_deC) | 4 | ASP A 189SER A 188SER A 250CYH A 438 | None | 1.04A | 3m0wE-1js6A:undetectable3m0wF-1js6A:undetectable3m0wG-1js6A:undetectable3m0wH-1js6A:undetectable | 3m0wE-1js6A:11.273m0wF-1js6A:11.273m0wG-1js6A:11.273m0wH-1js6A:11.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k8m | E2 COMPONENT OFBRANCHED-CHAINALPHA-KETOACIDDEHYDROGENASE (Homo sapiens) |
PF00364(Biotin_lipoyl) | 4 | ASP A 85SER A 10CYH A 39LEU A 75 | None | 1.04A | 3m0wE-1k8mA:undetectable3m0wF-1k8mA:undetectable3m0wG-1k8mA:undetectable3m0wH-1k8mA:undetectable | 3m0wE-1k8mA:19.613m0wF-1k8mA:19.613m0wG-1k8mA:19.613m0wH-1k8mA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l8k | T-CELLPROTEIN-TYROSINEPHOSPHATASE (Homo sapiens) |
PF00102(Y_phosphatase) | 4 | SER A 268PHE A 195LEU A 233ASP A 230 | None | 1.04A | 3m0wE-1l8kA:undetectable3m0wF-1l8kA:undetectable3m0wG-1l8kA:undetectable3m0wH-1l8kA:undetectable | 3m0wE-1l8kA:14.423m0wF-1l8kA:14.423m0wG-1l8kA:14.423m0wH-1l8kA:14.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) |
PF00061(Lipocalin) | 4 | PHE A 70CYH A 82LEU A 74ASP A 73 | None | 1.00A | 3m0wE-1mx8A:undetectable3m0wF-1mx8A:undetectable3m0wG-1mx8A:undetectable3m0wH-1mx8A:undetectable | 3m0wE-1mx8A:20.903m0wF-1mx8A:20.903m0wG-1mx8A:20.903m0wH-1mx8A:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1via | SHIKIMATE KINASE (Campylobacterjejuni) |
PF01202(SKI) | 4 | ASP A 34SER A 116LEU A 110ASP A 111 | None | 1.00A | 3m0wE-1viaA:undetectable3m0wF-1viaA:undetectable3m0wG-1viaA:undetectable3m0wH-1viaA:undetectable | 3m0wE-1viaA:22.763m0wF-1viaA:22.763m0wG-1viaA:22.763m0wH-1viaA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vp4 | AMINOTRANSFERASE,PUTATIVE (Thermotogamaritima) |
PF00155(Aminotran_1_2) | 4 | ASP A 277SER A 280LEU A 110ASP A 111 | None | 0.79A | 3m0wE-1vp4A:undetectable3m0wF-1vp4A:undetectable3m0wG-1vp4A:undetectable3m0wH-1vp4A:undetectable | 3m0wE-1vp4A:13.213m0wF-1vp4A:13.213m0wG-1vp4A:13.213m0wH-1vp4A:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w61 | B-CELL MITOGEN (Trypanosomacruzi) |
PF05544(Pro_racemase) | 4 | PHE A 120SER A 134LEU A 116ASP A 161 | None | 0.81A | 3m0wE-1w61A:undetectable3m0wF-1w61A:undetectable3m0wG-1w61A:undetectable3m0wH-1w61A:undetectable | 3m0wE-1w61A:13.333m0wF-1w61A:13.333m0wG-1w61A:13.333m0wH-1w61A:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z8l | GLUTAMATECARBOXYPEPTIDASE II (Homo sapiens) |
PF02225(PA)PF04253(TFR_dimer)PF04389(Peptidase_M28) | 4 | ASP A 714SER A 717LEU A 188ASP A 184 | None | 1.00A | 3m0wE-1z8lA:undetectable3m0wF-1z8lA:undetectable3m0wG-1z8lA:undetectable3m0wH-1z8lA:undetectable | 3m0wE-1z8lA:9.253m0wF-1z8lA:9.253m0wG-1z8lA:9.253m0wH-1z8lA:9.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a4e | CADHERIN-11 (Mus musculus) |
PF00028(Cadherin) | 4 | ASP A 134SER A 141LEU A 63ASP A 64 | CA A 301 ( 3.3A)NoneNone CA A 303 (-2.9A) | 1.07A | 3m0wE-2a4eA:undetectable3m0wF-2a4eA:undetectable3m0wG-2a4eA:undetectable3m0wH-2a4eA:undetectable | 3m0wE-2a4eA:18.983m0wF-2a4eA:18.983m0wG-2a4eA:18.983m0wH-2a4eA:18.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2an1 | PUTATIVE KINASE (Salmonellaenterica) |
PF01513(NAD_kinase) | 4 | PHE A 170SER A 173LEU A 231ASP A 257 | PHE A 170 ( 1.3A)SER A 173 ( 0.0A)LEU A 231 ( 0.5A)ASP A 257 ( 0.6A) | 1.06A | 3m0wE-2an1A:undetectable3m0wF-2an1A:undetectable3m0wG-2an1A:undetectable3m0wH-2an1A:undetectable | 3m0wE-2an1A:13.793m0wF-2an1A:13.793m0wG-2an1A:13.793m0wH-2an1A:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b5d | ALPHA-AMYLASE (Thermotogamaritima) |
PF03065(Glyco_hydro_57)PF09210(DUF1957) | 4 | ASP X 349PHE X 8SER X 56LEU X 183 | None | 1.00A | 3m0wE-2b5dX:undetectable3m0wF-2b5dX:undetectable3m0wG-2b5dX:undetectable3m0wH-2b5dX:undetectable | 3m0wE-2b5dX:12.213m0wF-2b5dX:12.213m0wG-2b5dX:12.213m0wH-2b5dX:12.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b5m | DAMAGE-SPECIFIC DNABINDING PROTEIN 1 (Homo sapiens) |
PF03178(CPSF_A)PF10433(MMS1_N) | 4 | SER A 730SER A 818LEU A 821ASP A 824 | None | 1.05A | 3m0wE-2b5mA:undetectable3m0wF-2b5mA:undetectable3m0wG-2b5mA:undetectable3m0wH-2b5mA:undetectable | 3m0wE-2b5mA:7.203m0wF-2b5mA:7.203m0wG-2b5mA:7.203m0wH-2b5mA:7.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cfa | THYMIDYLATE SYNTHASE (ParameciumbursariaChlorella virus1) |
PF02511(Thy1) | 4 | SER B 81CYH B 198PHE B 202LEU B 194 | FAD B1217 (-2.6A)NoneNoneNone | 1.04A | 3m0wE-2cfaB:undetectable3m0wF-2cfaB:undetectable3m0wG-2cfaB:undetectable3m0wH-2cfaB:undetectable | 3m0wE-2cfaB:18.043m0wF-2cfaB:18.043m0wG-2cfaB:18.043m0wH-2cfaB:18.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f2a | ASPARTYL/GLUTAMYL-TRNA(ASN/GLN)AMIDOTRANSFERASESUBUNIT BGLUTAMYL-TRNA(GLN)AMIDOTRANSFERASESUBUNIT A (Staphylococcusaureus) |
PF01425(Amidase)PF02637(GatB_Yqey)PF02934(GatB_N) | 4 | ASP B 274SER A 208PHE B 270SER A 319 | None | 1.00A | 3m0wE-2f2aB:undetectable3m0wF-2f2aB:undetectable3m0wG-2f2aB:undetectable3m0wH-2f2aB:undetectable | 3m0wE-2f2aB:13.933m0wF-2f2aB:13.933m0wG-2f2aB:13.933m0wH-2f2aB:13.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g18 | PHYCOCYANOBILIN:FERREDOXINOXIDOREDUCTASE (Anabaena sp.) |
PF05996(Fe_bilin_red) | 4 | SER A 118PHE A 99LEU A 103ASP A 102 | None | 1.06A | 3m0wE-2g18A:undetectable3m0wF-2g18A:undetectable3m0wG-2g18A:undetectable3m0wH-2g18A:undetectable | 3m0wE-2g18A:18.033m0wF-2g18A:18.033m0wG-2g18A:18.033m0wH-2g18A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hmf | PROBABLEASPARTOKINASE (Methanocaldococcusjannaschii) |
PF00696(AA_kinase)PF01842(ACT)PF13840(ACT_7) | 4 | PHE A 449CYH A 405LEU A 456ASP A 455 | None | 1.07A | 3m0wE-2hmfA:undetectable3m0wF-2hmfA:1.13m0wG-2hmfA:1.13m0wH-2hmfA:1.0 | 3m0wE-2hmfA:12.223m0wF-2hmfA:12.223m0wG-2hmfA:12.223m0wH-2hmfA:12.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ml6 | UNCHARACTERIZEDPROTEIN (Bacteroidesuniformis) |
no annotation | 4 | PHE A 88SER A 76PHE A 14ASP A 57 | None | 0.85A | 3m0wE-2ml6A:undetectable3m0wF-2ml6A:undetectable3m0wG-2ml6A:undetectable3m0wH-2ml6A:undetectable | 3m0wE-2ml6A:24.833m0wF-2ml6A:24.833m0wG-2ml6A:24.833m0wH-2ml6A:24.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2n57 | ACYL CARRIER PROTEIN (Brucellamelitensis) |
PF00550(PP-binding) | 4 | ASP A 57SER A 37PHE A 72LEU A 43 | None | 0.90A | 3m0wE-2n57A:undetectable3m0wF-2n57A:2.13m0wG-2n57A:2.13m0wH-2n57A:undetectable | 3m0wE-2n57A:20.593m0wF-2n57A:20.593m0wG-2n57A:20.593m0wH-2n57A:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o7q | BIFUNCTIONAL3-DEHYDROQUINATEDEHYDRATASE/SHIKIMATE DEHYDROGENASE (Arabidopsisthaliana) |
PF01487(DHquinase_I)PF01488(Shikimate_DH)PF08501(Shikimate_dh_N) | 4 | SER A 429PHE A 575LEU A 468ASP A 423 | NoneNoneNoneDHK A4733 (-2.8A) | 1.01A | 3m0wE-2o7qA:undetectable3m0wF-2o7qA:undetectable3m0wG-2o7qA:undetectable3m0wH-2o7qA:undetectable | 3m0wE-2o7qA:11.313m0wF-2o7qA:11.313m0wG-2o7qA:11.313m0wH-2o7qA:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p5i | BH3822 PROTEIN (Bacillushalodurans) |
PF03099(BPL_LplA_LipB) | 4 | PHE A 27SER A 32LEU A 18ASP A 19 | None | 1.00A | 3m0wE-2p5iA:undetectable3m0wF-2p5iA:undetectable3m0wG-2p5iA:undetectable3m0wH-2p5iA:undetectable | 3m0wE-2p5iA:20.003m0wF-2p5iA:20.003m0wG-2p5iA:20.003m0wH-2p5iA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pjp | SELENOCYSTEINE-SPECIFIC ELONGATIONFACTOR (Escherichiacoli) |
PF09107(SelB-wing_3) | 4 | ASP A 607PHE A 590LEU A 560ASP A 561 | NoneNoneNone CA A 102 (-3.1A) | 0.83A | 3m0wE-2pjpA:undetectable3m0wF-2pjpA:undetectable3m0wG-2pjpA:undetectable3m0wH-2pjpA:undetectable | 3m0wE-2pjpA:22.483m0wF-2pjpA:22.483m0wG-2pjpA:22.483m0wH-2pjpA:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zvi | 2,3-DIKETO-5-METHYLTHIOPENTYL-1-PHOSPHATE ENOLASE (Bacillussubtilis) |
PF00016(RuBisCO_large)PF02788(RuBisCO_large_N) | 4 | PHE A 115CYH A 295LEU A 248ASP A 249 | None | 1.06A | 3m0wE-2zviA:undetectable3m0wF-2zviA:undetectable3m0wG-2zviA:undetectable3m0wH-2zviA:undetectable | 3m0wE-2zviA:13.993m0wF-2zviA:13.993m0wG-2zviA:13.993m0wH-2zviA:13.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3al0 | ASPARTYL/GLUTAMYL-TRNA(ASN/GLN)AMIDOTRANSFERASESUBUNIT BGLUTAMYL-TRNA(GLN)AMIDOTRANSFERASESUBUNIT A (Thermotogamaritima) |
PF01425(Amidase)PF02637(GatB_Yqey)PF02934(GatB_N) | 4 | ASP B 281SER A 195PHE B 277SER A 305 | None | 1.05A | 3m0wE-3al0B:undetectable3m0wF-3al0B:undetectable3m0wG-3al0B:undetectable3m0wH-3al0B:undetectable | 3m0wE-3al0B:13.923m0wF-3al0B:13.923m0wG-3al0B:13.923m0wH-3al0B:13.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bpt | 3-HYDROXYISOBUTYRYL-COA HYDROLASE (Homo sapiens) |
PF16113(ECH_2) | 4 | CYH A 336PHE A 342LEU A 332ASP A 177 | NoneNoneNoneHIU A 502 (-2.8A) | 1.06A | 3m0wE-3bptA:0.33m0wF-3bptA:undetectable3m0wG-3bptA:undetectable3m0wH-3bptA:undetectable | 3m0wE-3bptA:16.453m0wF-3bptA:16.453m0wG-3bptA:16.453m0wH-3bptA:16.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cc8 | PUTATIVEMETHYLTRANSFERASE (Bacillus cereus) |
PF13489(Methyltransf_23) | 5 | ASP A 100SER A 128PHE A 218LEU A 154ASP A 155 | NoneNoneNoneNone NI A 231 (-4.2A) | 1.46A | 3m0wE-3cc8A:undetectable3m0wF-3cc8A:undetectable3m0wG-3cc8A:undetectable3m0wH-3cc8A:undetectable | 3m0wE-3cc8A:19.023m0wF-3cc8A:19.023m0wG-3cc8A:19.023m0wH-3cc8A:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cf0 | TRANSITIONALENDOPLASMICRETICULUM ATPASE (Mus musculus) |
PF00004(AAA)PF09336(Vps4_C) | 4 | ASP A 484SER A 652CYH A 522LEU A 647 | None | 1.03A | 3m0wE-3cf0A:undetectable3m0wF-3cf0A:1.43m0wG-3cf0A:1.63m0wH-3cf0A:undetectable | 3m0wE-3cf0A:18.033m0wF-3cf0A:18.033m0wG-3cf0A:18.033m0wH-3cf0A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) |
PF00069(Pkinase) | 4 | SER A 362SER A 159LEU A 57ASP A 58 | None | 0.86A | 3m0wE-3eb0A:undetectable3m0wF-3eb0A:undetectable3m0wG-3eb0A:undetectable3m0wH-3eb0A:undetectable | 3m0wE-3eb0A:12.273m0wF-3eb0A:12.273m0wG-3eb0A:12.273m0wH-3eb0A:12.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h6e | CARBOHYDRATE KINASE,FGGY (Novosphingobiumaromaticivorans) |
PF00370(FGGY_N) | 4 | SER A 184PHE A 196LEU A 134ASP A 135 | None | 0.98A | 3m0wE-3h6eA:undetectable3m0wF-3h6eA:undetectable3m0wG-3h6eA:undetectable3m0wH-3h6eA:undetectable | 3m0wE-3h6eA:12.023m0wF-3h6eA:12.023m0wG-3h6eA:12.023m0wH-3h6eA:12.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i8b | XYLULOSE KINASE (Bifidobacteriumadolescentis) |
PF00370(FGGY_N)PF02782(FGGY_C) | 4 | SER A 295SER A 291PHE A 316ASP A 273 | None | 0.81A | 3m0wE-3i8bA:undetectable3m0wF-3i8bA:undetectable3m0wG-3i8bA:undetectable3m0wH-3i8bA:undetectable | 3m0wE-3i8bA:10.603m0wF-3i8bA:10.603m0wG-3i8bA:10.603m0wH-3i8bA:10.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jty | BENF-LIKE PORIN (Pseudomonasprotegens) |
PF03573(OprD) | 4 | ASP A 317SER A 322PHE A 238LEU A 148 | None | 1.06A | 3m0wE-3jtyA:undetectable3m0wF-3jtyA:undetectable3m0wG-3jtyA:undetectable3m0wH-3jtyA:undetectable | 3m0wE-3jtyA:14.213m0wF-3jtyA:14.213m0wG-3jtyA:14.213m0wH-3jtyA:14.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kfu | ASPARTYL/GLUTAMYL-TRNA(ASN/GLN)AMIDOTRANSFERASESUBUNIT BGLUTAMYL-TRNA(GLN)AMIDOTRANSFERASESUBUNIT A (Thermusthermophilus) |
PF01425(Amidase)PF02637(GatB_Yqey)PF02934(GatB_N) | 4 | ASP F 269SER E 195PHE F 265SER E 304 | None | 1.04A | 3m0wE-3kfuF:undetectable3m0wF-3kfuF:undetectable3m0wG-3kfuF:undetectable3m0wH-3kfuF:undetectable | 3m0wE-3kfuF:10.583m0wF-3kfuF:10.583m0wG-3kfuF:10.583m0wH-3kfuF:10.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lij | CALCIUM/CALMODULINDEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) |
PF00069(Pkinase)PF13499(EF-hand_7) | 4 | ASP A 425PHE A 50LEU A 116ASP A 117 | CA A 518 (-3.2A)NoneNoneNone | 0.72A | 3m0wE-3lijA:6.93m0wF-3lijA:6.93m0wG-3lijA:6.83m0wH-3lijA:5.8 | 3m0wE-3lijA:12.183m0wF-3lijA:12.183m0wG-3lijA:12.183m0wH-3lijA:12.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m2t | PROBABLEDEHYDROGENASE (Chromobacteriumviolaceum) |
PF01408(GFO_IDH_MocA) | 4 | SER A 116SER A 120PHE A 80LEU A 314 | None | 1.00A | 3m0wE-3m2tA:undetectable3m0wF-3m2tA:undetectable3m0wG-3m2tA:undetectable3m0wH-3m2tA:undetectable | 3m0wE-3m2tA:15.123m0wF-3m2tA:15.123m0wG-3m2tA:15.123m0wH-3m2tA:15.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mca | ELONGATION FACTOR 1ALPHA-LIKE PROTEINPROTEIN DOM34 (Schizosaccharomycespombe) |
PF00009(GTP_EFTU)PF03143(GTP_EFTU_D3)PF03463(eRF1_1)PF03464(eRF1_2)PF03465(eRF1_3) | 4 | ASP A 483SER A 440PHE A 560LEU B 146 | None | 0.99A | 3m0wE-3mcaA:undetectable3m0wF-3mcaA:undetectable3m0wG-3mcaA:undetectable3m0wH-3mcaA:undetectable | 3m0wE-3mcaA:10.533m0wF-3mcaA:10.533m0wG-3mcaA:10.533m0wH-3mcaA:10.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mvj | CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA (Homo sapiens) |
PF00069(Pkinase) | 4 | PHE A 314PHE A 145LEU A 173ASP A 175 | NoneNoneXFE A 351 (-4.6A)None | 1.05A | 3m0wE-3mvjA:undetectable3m0wF-3mvjA:undetectable3m0wG-3mvjA:undetectable3m0wH-3mvjA:undetectable | 3m0wE-3mvjA:14.453m0wF-3mvjA:14.453m0wG-3mvjA:14.453m0wH-3mvjA:14.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oa2 | WBPB (Pseudomonasaeruginosa) |
PF01408(GFO_IDH_MocA)PF02894(GFO_IDH_MocA_C) | 4 | ASP A 234SER A 229PHE A 207SER A 209 | None | 0.94A | 3m0wE-3oa2A:undetectable3m0wF-3oa2A:undetectable3m0wG-3oa2A:undetectable3m0wH-3oa2A:undetectable | 3m0wE-3oa2A:14.103m0wF-3oa2A:14.103m0wG-3oa2A:14.103m0wH-3oa2A:14.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qd9 | QSOX FROMTRYPANOSOMA BRUCEI(TBQSOX) (Trypanosomabrucei) |
PF00085(Thioredoxin)PF04777(Evr1_Alr) | 4 | ASP A 37PHE A 79LEU A 43ASP A 42 | None | 0.94A | 3m0wE-3qd9A:1.93m0wF-3qd9A:1.03m0wG-3qd9A:1.93m0wH-3qd9A:1.8 | 3m0wE-3qd9A:13.233m0wF-3qd9A:13.233m0wG-3qd9A:13.233m0wH-3qd9A:13.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rbl | AROMATIC L-AMINOACID DECARBOXYLASE (Homo sapiens) |
PF00282(Pyridoxal_deC) | 4 | ASP A 189SER A 188SER A 250CYH A 438 | None | 0.98A | 3m0wE-3rblA:undetectable3m0wF-3rblA:undetectable3m0wG-3rblA:undetectable3m0wH-3rblA:undetectable | 3m0wE-3rblA:12.703m0wF-3rblA:12.703m0wG-3rblA:12.703m0wH-3rblA:12.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sqn | CONSERVED DOMAINPROTEIN (Enterococcusfaecalis) |
PF05043(Mga) | 4 | SER A 226PHE A 262SER A 332LEU A 321 | None | 0.97A | 3m0wE-3sqnA:undetectable3m0wF-3sqnA:undetectable3m0wG-3sqnA:undetectable3m0wH-3sqnA:undetectable | 3m0wE-3sqnA:14.323m0wF-3sqnA:14.323m0wG-3sqnA:14.323m0wH-3sqnA:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t5t | PUTATIVEGLYCOSYLTRANSFERASE (Streptomyceshygroscopicus) |
PF00982(Glyco_transf_20) | 4 | ASP A 383SER A 380PHE A 378PHE A 390 | None | 0.93A | 3m0wE-3t5tA:undetectable3m0wF-3t5tA:undetectable3m0wG-3t5tA:undetectable3m0wH-3t5tA:undetectable | 3m0wE-3t5tA:11.453m0wF-3t5tA:11.453m0wG-3t5tA:11.453m0wH-3t5tA:11.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 4 | ASP A 103SER A 107SER A 433LEU A 33 | QNB A1162 (-3.1A)QNB A1162 (-3.4A)NoneNone | 1.04A | 3m0wE-3uonA:undetectable3m0wF-3uonA:undetectable3m0wG-3uonA:undetectable3m0wH-3uonA:undetectable | 3m0wE-3uonA:12.973m0wF-3uonA:12.973m0wG-3uonA:12.973m0wH-3uonA:12.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zdn | MONOAMINE OXIDASE N (Aspergillusniger) |
PF01593(Amino_oxidase) | 4 | SER A 223PHE A 431PHE A 466LEU A 461 | NoneNoneFAD A1487 (-4.8A)None | 0.92A | 3m0wE-3zdnA:undetectable3m0wF-3zdnA:undetectable3m0wG-3zdnA:0.33m0wH-3zdnA:0.4 | 3m0wE-3zdnA:10.553m0wF-3zdnA:10.553m0wG-3zdnA:10.553m0wH-3zdnA:10.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c7v | TRANSKETOLASE (Lactobacillussalivarius) |
PF00456(Transketolase_N)PF02779(Transket_pyr)PF02780(Transketolase_C) | 4 | SER A 17PHE A 222LEU A 184ASP A 186 | None | 0.83A | 3m0wE-4c7vA:undetectable3m0wF-4c7vA:undetectable3m0wG-4c7vA:1.63m0wH-4c7vA:1.8 | 3m0wE-4c7vA:9.223m0wF-4c7vA:9.223m0wG-4c7vA:9.223m0wH-4c7vA:9.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eco | UNCHARACTERIZEDPROTEIN (Bacteroideseggerthii) |
no annotation | 4 | ASP A 421PHE A 426SER A 729ASP A 676 | None | 0.93A | 3m0wE-4ecoA:undetectable3m0wF-4ecoA:undetectable3m0wG-4ecoA:undetectable3m0wH-4ecoA:undetectable | 3m0wE-4ecoA:9.903m0wF-4ecoA:9.903m0wG-4ecoA:9.903m0wH-4ecoA:9.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4euo | ABC TRANSPORTER,SUBSTRATE BINDINGPROTEIN (POLYAMINE) (Agrobacteriumfabrum) |
PF13416(SBP_bac_8) | 4 | ASP A 305SER A 291LEU A 108ASP A 109 | None | 1.03A | 3m0wE-4euoA:undetectable3m0wF-4euoA:undetectable3m0wG-4euoA:undetectable3m0wH-4euoA:undetectable | 3m0wE-4euoA:14.523m0wF-4euoA:14.523m0wG-4euoA:14.523m0wH-4euoA:14.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f0g | SERINE/THREONINE-PROTEIN KINASE ROCO4 (Dictyosteliumdiscoideum) |
PF07714(Pkinase_Tyr) | 4 | SER A1127CYH A1172LEU A1165ASP A1166 | None | 1.06A | 3m0wE-4f0gA:1.13m0wF-4f0gA:undetectable3m0wG-4f0gA:1.03m0wH-4f0gA:0.9 | 3m0wE-4f0gA:16.063m0wF-4f0gA:16.063m0wG-4f0gA:16.063m0wH-4f0gA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fbv | MYXOBACTERIALHEMAGGLUTININ (Myxococcusxanthus) |
no annotation | 4 | ASP A 29SER A 139LEU A 159ASP A 136 | None | 0.98A | 3m0wE-4fbvA:undetectable3m0wF-4fbvA:undetectable3m0wG-4fbvA:undetectable3m0wH-4fbvA:undetectable | 3m0wE-4fbvA:13.163m0wF-4fbvA:13.163m0wG-4fbvA:13.163m0wH-4fbvA:13.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fid | G PROTEIN ALPHASUBUNIT (Entamoebahistolytica) |
PF00503(G-alpha) | 4 | ASP A 111SER A 91PHE A 104LEU A 140 | None | 0.99A | 3m0wE-4fidA:undetectable3m0wF-4fidA:undetectable3m0wG-4fidA:undetectable3m0wH-4fidA:undetectable | 3m0wE-4fidA:15.253m0wF-4fidA:15.253m0wG-4fidA:15.253m0wH-4fidA:15.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g1c | NAD-DEPENDENTPROTEIN DEACYLASESIRTUIN-5,MITOCHONDRIAL (Homo sapiens) |
PF02146(SIR2) | 4 | ASP A 143SER A 62SER A 57LEU A 155 | CNA A 402 (-3.7A)CNA A 402 ( 4.1A)NoneNone | 0.84A | 3m0wE-4g1cA:undetectable3m0wF-4g1cA:undetectable3m0wG-4g1cA:undetectable3m0wH-4g1cA:undetectable | 3m0wE-4g1cA:20.953m0wF-4g1cA:20.953m0wG-4g1cA:20.953m0wH-4g1cA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gl9 | TYROSINE-PROTEINKINASE (Mus musculus) |
PF07714(Pkinase_Tyr) | 4 | SER A1029SER A1035LEU A 977ASP A 976 | None | 1.00A | 3m0wE-4gl9A:undetectable3m0wF-4gl9A:0.63m0wG-4gl9A:undetectable3m0wH-4gl9A:0.6 | 3m0wE-4gl9A:17.763m0wF-4gl9A:17.763m0wG-4gl9A:17.763m0wH-4gl9A:17.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h8a | UREIDOGLYCOLATEDEHYDROGENASE (Escherichiacoli) |
PF02615(Ldh_2) | 4 | ASP A 174PHE A 123SER A 117LEU A 33 | NAI A 401 (-2.7A)NoneNAI A 401 ( 4.5A)None | 1.01A | 3m0wE-4h8aA:undetectable3m0wF-4h8aA:undetectable3m0wG-4h8aA:undetectable3m0wH-4h8aA:undetectable | 3m0wE-4h8aA:13.893m0wF-4h8aA:13.893m0wG-4h8aA:13.893m0wH-4h8aA:13.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hjl | NAPHTHALENE1,2-DIOXYGENASESUBUNIT ALPHANAPHTHALENE1,2-DIOXYGENASESUBUNIT BETA (Pseudomonas sp.C18) |
PF00355(Rieske)PF00848(Ring_hydroxyl_A)PF00866(Ring_hydroxyl_B) | 4 | ASP A 361SER A 360LEU B 102ASP B 103 | None | 1.02A | 3m0wE-4hjlA:undetectable3m0wF-4hjlA:undetectable3m0wG-4hjlA:undetectable3m0wH-4hjlA:undetectable | 3m0wE-4hjlA:10.543m0wF-4hjlA:10.543m0wG-4hjlA:10.543m0wH-4hjlA:10.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iw7 | 8-AMINO-7-OXONONANOATE SYNTHASE (Francisellatularensis) |
PF00155(Aminotran_1_2) | 4 | ASP A 299SER A 297PHE A 162LEU A 174 | None | 0.94A | 3m0wE-4iw7A:undetectable3m0wF-4iw7A:undetectable3m0wG-4iw7A:undetectable3m0wH-4iw7A:undetectable | 3m0wE-4iw7A:15.323m0wF-4iw7A:15.323m0wG-4iw7A:15.323m0wH-4iw7A:15.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k3x | HEMAGGLUTININ HA1HEMAGGLUTININ HA2 (Influenza Avirus) |
PF00509(Hemagglutinin) | 4 | SER B 65SER A 113LEU A 108ASP A 107 | None | 0.95A | 3m0wE-4k3xB:0.83m0wF-4k3xB:0.93m0wG-4k3xB:undetectable3m0wH-4k3xB:undetectable | 3m0wE-4k3xB:22.293m0wF-4k3xB:22.293m0wG-4k3xB:22.293m0wH-4k3xB:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kru | AUTOLYTIC LYSOZYME (Clostridiumphage phiSM101) |
PF01183(Glyco_hydro_25) | 4 | ASP A 77PHE A 120LEU A 86ASP A 84 | None | 1.02A | 3m0wE-4kruA:undetectable3m0wF-4kruA:undetectable3m0wG-4kruA:undetectable3m0wH-4kruA:undetectable | 3m0wE-4kruA:18.943m0wF-4kruA:18.943m0wG-4kruA:18.943m0wH-4kruA:18.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l3a | INTERNALIN K (Listeriamonocytogenes) |
no annotation | 4 | SER A 343PHE A 203LEU A 178ASP A 177 | NoneNoneNone NA A 603 (-3.4A) | 1.01A | 3m0wE-4l3aA:undetectable3m0wF-4l3aA:undetectable3m0wG-4l3aA:undetectable3m0wH-4l3aA:undetectable | 3m0wE-4l3aA:10.813m0wF-4l3aA:10.813m0wG-4l3aA:10.813m0wH-4l3aA:10.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l6u | PUTATIVEUNCHARACTERIZEDPROTEIN (Archaeoglobusfulgidus) |
PF03787(RAMPs) | 4 | SER A 45PHE A 64SER A 132LEU A 126 | None | 1.05A | 3m0wE-4l6uA:undetectable3m0wF-4l6uA:undetectable3m0wG-4l6uA:undetectable3m0wH-4l6uA:undetectable | 3m0wE-4l6uA:14.723m0wF-4l6uA:14.723m0wG-4l6uA:14.723m0wH-4l6uA:14.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mc5 | HEMAGGLUTININ (Influenza Avirus) |
PF00509(Hemagglutinin) | 4 | SER A 394SER A 110LEU A 105ASP A 104 | None | 0.94A | 3m0wE-4mc5A:0.83m0wF-4mc5A:0.83m0wG-4mc5A:undetectable3m0wH-4mc5A:0.8 | 3m0wE-4mc5A:10.743m0wF-4mc5A:10.743m0wG-4mc5A:10.743m0wH-4mc5A:10.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mnd | CTPL-MYO-INOSITOL-1-PHOSPHATECYTIDYLYLTRANSFERASE/CDP-L-MYO-INOSITOLMYO-INOSITOLPHOSPHOTRANSFERASE (Archaeoglobusfulgidus) |
PF01066(CDP-OH_P_transf)PF12804(NTP_transf_3) | 4 | ASP A 386SER A 335LEU A 356ASP A 357 | NoneNoneNone MG A 605 (-3.8A) | 0.96A | 3m0wE-4mndA:undetectable3m0wF-4mndA:undetectable3m0wG-4mndA:undetectable3m0wH-4mndA:undetectable | 3m0wE-4mndA:12.663m0wF-4mndA:12.663m0wG-4mndA:12.663m0wH-4mndA:12.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qnl | TAIL FIBER PROTEIN (Escherichiavirus G7C) |
no annotation | 4 | SER A 314SER A 342CYH A 375LEU A 377 | None | 1.01A | 3m0wE-4qnlA:undetectable3m0wF-4qnlA:undetectable3m0wG-4qnlA:undetectable3m0wH-4qnlA:undetectable | 3m0wE-4qnlA:9.993m0wF-4qnlA:9.993m0wG-4qnlA:9.993m0wH-4qnlA:9.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rcm | METHYLATEDRNA-BINDING PROTEIN1 (Saccharomycescerevisiae) |
PF04146(YTH) | 4 | ASP A 274CYH A 213PHE A 212LEU A 165 | NoneNoneNoneUNX A 401 ( 4.7A) | 1.02A | 3m0wE-4rcmA:undetectable3m0wF-4rcmA:undetectable3m0wG-4rcmA:undetectable3m0wH-4rcmA:undetectable | 3m0wE-4rcmA:22.293m0wF-4rcmA:22.293m0wG-4rcmA:22.293m0wH-4rcmA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rh7 | GREEN FLUORESCENTPROTEIN/CYTOPLASMICDYNEIN 2 HEAVY CHAIN1 (Homo sapiens;syntheticconstruct) |
PF03028(Dynein_heavy)PF07728(AAA_5)PF08393(DHC_N2)PF12774(AAA_6)PF12775(AAA_7)PF12777(MT)PF12780(AAA_8)PF12781(AAA_9) | 4 | ASP A2031SER A2080LEU A1437ASP A1435 | None | 1.04A | 3m0wE-4rh7A:undetectable3m0wF-4rh7A:undetectable3m0wG-4rh7A:undetectable3m0wH-4rh7A:undetectable | 3m0wE-4rh7A:2.963m0wF-4rh7A:2.963m0wG-4rh7A:2.963m0wH-4rh7A:2.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u8t | ZYRO0G01672P (Zygosaccharomycesrouxii) |
PF04146(YTH) | 5 | ASP A 297SER A 202CYH A 236PHE A 235LEU A 188 | C O 1 ( 4.8A)NoneNoneNoneNone | 1.17A | 3m0wE-4u8tA:undetectable3m0wF-4u8tA:undetectable3m0wG-4u8tA:undetectable3m0wH-4u8tA:undetectable | 3m0wE-4u8tA:20.123m0wF-4u8tA:20.123m0wG-4u8tA:20.123m0wH-4u8tA:20.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u9p | UPF0264 PROTEINMJ1099 (Methanocaldococcusjannaschii) |
PF04476(4HFCP_synth) | 4 | ASP A 25SER A 56LEU A 150ASP A 151 | None | 0.94A | 3m0wE-4u9pA:undetectable3m0wF-4u9pA:undetectable3m0wG-4u9pA:undetectable3m0wH-4u9pA:undetectable | 3m0wE-4u9pA:16.143m0wF-4u9pA:16.143m0wG-4u9pA:16.143m0wH-4u9pA:16.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4udr | GLUCOSE-METHANOL-CHOLINE OXIDOREDUCTASE (Methylovorussp. MP688) |
PF00732(GMC_oxred_N)PF05199(GMC_oxred_C) | 4 | ASP A 350PHE A 368LEU A 403ASP A 402 | None | 0.92A | 3m0wE-4udrA:undetectable3m0wF-4udrA:undetectable3m0wG-4udrA:undetectable3m0wH-4udrA:undetectable | 3m0wE-4udrA:10.663m0wF-4udrA:10.663m0wG-4udrA:10.663m0wH-4udrA:10.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wkr | LA-RELATED PROTEIN 7 (Homo sapiens) |
PF00076(RRM_1)PF05383(La) | 4 | ASP A 66SER A 64LEU A 102ASP A 103 | None | 0.74A | 3m0wE-4wkrA:undetectable3m0wF-4wkrA:undetectable3m0wG-4wkrA:undetectable3m0wH-4wkrA:undetectable | 3m0wE-4wkrA:19.713m0wF-4wkrA:19.713m0wG-4wkrA:19.713m0wH-4wkrA:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y0w | YEAZ (Pseudomonasaeruginosa) |
PF00814(Peptidase_M22) | 4 | ASP A 95SER A 10SER A 15LEU A 192 | None NA A 302 (-3.5A)NoneNone | 1.02A | 3m0wE-4y0wA:undetectable3m0wF-4y0wA:undetectable3m0wG-4y0wA:undetectable3m0wH-4y0wA:undetectable | 3m0wE-4y0wA:14.663m0wF-4y0wA:14.663m0wG-4y0wA:14.663m0wH-4y0wA:14.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zwv | PUTATIVEAMINOTRANSFERASE (Actinomaduramelliaura) |
PF01041(DegT_DnrJ_EryC1) | 4 | ASP A 285SER A 283LEU A 138ASP A 136 | None | 0.98A | 3m0wE-4zwvA:undetectable3m0wF-4zwvA:undetectable3m0wG-4zwvA:undetectable3m0wH-4zwvA:undetectable | 3m0wE-4zwvA:14.133m0wF-4zwvA:14.133m0wG-4zwvA:14.133m0wH-4zwvA:14.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ady | GTPASE HFLX (Escherichiacoli) |
PF01926(MMR_HSR1)PF13167(GTP-bdg_N)PF16360(GTP-bdg_M) | 4 | ASP 6 288SER 6 32LEU 6 27ASP 6 26 | None | 0.73A | 3m0wE-5ady6:undetectable3m0wF-5ady6:undetectable3m0wG-5ady6:undetectable3m0wH-5ady6:undetectable | 3m0wE-5ady6:12.023m0wF-5ady6:12.023m0wG-5ady6:12.023m0wH-5ady6:12.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5bp1 | MYCOCEROSIC ACIDSYNTHASE (Mycolicibacteriumsmegmatis) |
PF00109(ketoacyl-synt)PF00698(Acyl_transf_1)PF02801(Ketoacyl-synt_C)PF16197(KAsynt_C_assoc) | 4 | SER A 762SER A 636LEU A 751ASP A 775 | None | 1.05A | 3m0wE-5bp1A:undetectable3m0wF-5bp1A:undetectable3m0wG-5bp1A:undetectable3m0wH-5bp1A:undetectable | 3m0wE-5bp1A:6.983m0wF-5bp1A:6.983m0wG-5bp1A:6.983m0wH-5bp1A:6.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5bsh | PYRROLINE-5-CARBOXYLATE REDUCTASE (Medicagotruncatula) |
PF03807(F420_oxidored)PF14748(P5CR_dimer) | 4 | ASP A 169SER A 141PHE A 122SER A 103 | None | 0.87A | 3m0wE-5bshA:2.63m0wF-5bshA:2.73m0wG-5bshA:2.73m0wH-5bshA:2.6 | 3m0wE-5bshA:15.753m0wF-5bshA:15.753m0wG-5bshA:15.753m0wH-5bshA:15.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cn1 | ADP-RIBOSYLATIONFACTOR-BINDINGPROTEIN GGA1 (Saccharomycescerevisiae) |
PF02883(Alpha_adaptinC2) | 4 | SER A 502PHE A 484LEU A 447ASP A 456 | None | 0.83A | 3m0wE-5cn1A:undetectable3m0wF-5cn1A:undetectable3m0wG-5cn1A:undetectable3m0wH-5cn1A:undetectable | 3m0wE-5cn1A:22.143m0wF-5cn1A:22.143m0wG-5cn1A:22.143m0wH-5cn1A:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5csl | ACETYL-COACARBOXYLASE (Saccharomycescerevisiae) |
PF00289(Biotin_carb_N)PF00364(Biotin_lipoyl)PF01039(Carboxyl_trans)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2)PF08326(ACC_central) | 4 | SER A 502PHE A 506SER A 461ASP A 535 | None | 0.98A | 3m0wE-5cslA:1.63m0wF-5cslA:undetectable3m0wG-5cslA:undetectable3m0wH-5cslA:undetectable | 3m0wE-5cslA:4.023m0wF-5cslA:4.023m0wG-5cslA:4.023m0wH-5cslA:4.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5czz | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Staphylococcusaureus) |
PF13395(HNH_4)PF16592(Cas9_REC) | 4 | PHE A 36SER A 453LEU A 9ASP A 10 | None | 0.98A | 3m0wE-5czzA:undetectable3m0wF-5czzA:undetectable3m0wG-5czzA:undetectable3m0wH-5czzA:undetectable | 3m0wE-5czzA:6.403m0wF-5czzA:6.403m0wG-5czzA:6.403m0wH-5czzA:6.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ddz | RICIN (Ricinuscommunis) |
PF00161(RIP) | 4 | ASP A 96PHE A 93LEU A 74ASP A 75 | None | 0.97A | 3m0wE-5ddzA:undetectable3m0wF-5ddzA:undetectable3m0wG-5ddzA:undetectable3m0wH-5ddzA:undetectable | 3m0wE-5ddzA:15.753m0wF-5ddzA:15.753m0wG-5ddzA:15.753m0wH-5ddzA:15.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eio | N-ACETYL-GAMMA-GLUTAMYL-PHOSPHATE/N-ACETYL-GAMMA-AMINOADIPYL-PHOSPHATE REDUCTASE (Thermusthermophilus) |
PF01118(Semialdhyde_dh)PF02774(Semialdhyde_dhC) | 4 | ASP A 85CYH A 124PHE A 101ASP A 120 | None | 1.03A | 3m0wE-5eioA:undetectable3m0wF-5eioA:undetectable3m0wG-5eioA:undetectable3m0wH-5eioA:undetectable | 3m0wE-5eioA:15.083m0wF-5eioA:15.083m0wG-5eioA:15.083m0wH-5eioA:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eso | 2-SUCCINYL-5-ENOLPYRUVYL-6-HYDROXY-3-CYCLOHEXENE-1-CARBOXYLATE SYNTHASE (Mycobacteriumtuberculosis) |
PF02776(TPP_enzyme_N) | 4 | SER A 430SER A 461LEU A 524ASP A 525 | None | 0.96A | 3m0wE-5esoA:undetectable3m0wF-5esoA:undetectable3m0wG-5esoA:undetectable3m0wH-5esoA:undetectable | 3m0wE-5esoA:10.093m0wF-5esoA:10.093m0wG-5esoA:10.093m0wH-5esoA:10.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f75 | THIOCYANATEDEHYDROGENASE (Thioalkalivibrioparadoxus) |
no annotation | 4 | ASP A 427SER A 425LEU A 477ASP A 476 | None | 1.07A | 3m0wE-5f75A:undetectable3m0wF-5f75A:undetectable3m0wG-5f75A:undetectable3m0wH-5f75A:undetectable | 3m0wE-5f75A:10.403m0wF-5f75A:10.403m0wG-5f75A:10.403m0wH-5f75A:10.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fbh | EXTRACELLULARCALCIUM-SENSINGRECEPTOR (Homo sapiens) |
no annotation | 4 | SER B 170SER B 296LEU B 276ASP B 275 | TCR B 609 (-2.8A)NoneNoneNone | 0.86A | 3m0wE-5fbhB:undetectable3m0wF-5fbhB:undetectable3m0wG-5fbhB:undetectable3m0wH-5fbhB:undetectable | 3m0wE-5fbhB:9.683m0wF-5fbhB:9.683m0wG-5fbhB:9.683m0wH-5fbhB:9.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hci | GPN-LOOP GTPASE 1 (Saccharomycescerevisiae) |
PF03029(ATP_bind_1) | 4 | ASP A 200SER A 146PHE A 193LEU A 217 | None | 1.05A | 3m0wE-5hciA:undetectable3m0wF-5hciA:undetectable3m0wG-5hciA:undetectable3m0wH-5hciA:undetectable | 3m0wE-5hciA:16.863m0wF-5hciA:16.863m0wG-5hciA:16.863m0wH-5hciA:16.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i2c | GATS-LIKE PROTEIN 3 (Homo sapiens) |
PF13840(ACT_7) | 4 | SER A 208PHE A 228CYH A 185PHE A 184 | None | 0.94A | 3m0wE-5i2cA:undetectable3m0wF-5i2cA:undetectable3m0wG-5i2cA:undetectable3m0wH-5i2cA:undetectable | 3m0wE-5i2cA:14.893m0wF-5i2cA:14.893m0wG-5i2cA:14.893m0wH-5i2cA:14.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jif | HEMAGGLUTININ-ESTERASE (Murinecoronavirus) |
PF02710(Hema_HEFG)PF03996(Hema_esterase) | 4 | ASP A 308SER A 81PHE A 322LEU A 137 | NoneNoneNAG A 818 ( 4.8A)None | 1.05A | 3m0wE-5jifA:undetectable3m0wF-5jifA:undetectable3m0wG-5jifA:undetectable3m0wH-5jifA:undetectable | 3m0wE-5jifA:14.253m0wF-5jifA:14.253m0wG-5jifA:14.253m0wH-5jifA:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jjq | AMP-DEPENDENTSYNTHETASE ANDLIGASE (Streptomycessp. ML694-90F3) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 4 | SER A 372CYH A 313PHE A 314LEU A 220 | NoneNone6L1 A 601 (-4.4A)None | 0.90A | 3m0wE-5jjqA:undetectable3m0wF-5jjqA:undetectable3m0wG-5jjqA:undetectable3m0wH-5jjqA:undetectable | 3m0wE-5jjqA:10.693m0wF-5jjqA:10.693m0wG-5jjqA:10.693m0wH-5jjqA:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jmc | SYNAPTIC VESICLEGLYCOPROTEIN 2C (Rattusnorvegicus) |
PF13599(Pentapeptide_4) | 4 | ASP B 546PHE B 507LEU B 503ASP B 524 | None | 0.97A | 3m0wE-5jmcB:undetectable3m0wF-5jmcB:undetectable3m0wG-5jmcB:undetectable3m0wH-5jmcB:undetectable | 3m0wE-5jmcB:22.663m0wF-5jmcB:22.663m0wG-5jmcB:22.663m0wH-5jmcB:22.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nec | TONB-DEPENDENTSIDEROPHORE RECEPTOR (Pseudomonasaeruginosa) |
no annotation | 4 | SER A 228PHE A 187LEU A 174ASP A 175 | None | 1.03A | 3m0wE-5necA:undetectable3m0wF-5necA:undetectable3m0wG-5necA:undetectable3m0wH-5necA:undetectable | 3m0wE-5necA:18.003m0wF-5necA:18.003m0wG-5necA:18.003m0wH-5necA:18.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o82 | INTRACELLULAREXO-ALPHA-(1->5)-L-ARABINOFURANOSIDASE (Chaetomiumthermophilum) |
no annotation | 4 | PHE A 221SER A 268LEU A 262ASP A 261 | None | 1.00A | 3m0wE-5o82A:undetectable3m0wF-5o82A:undetectable3m0wG-5o82A:undetectable3m0wH-5o82A:undetectable | 3m0wE-5o82A:26.263m0wF-5o82A:26.263m0wG-5o82A:26.263m0wH-5o82A:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vbb | RNA PSEUDOURIDYLATESYNTHASEDOMAIN-CONTAININGPROTEIN 1 (Homo sapiens) |
PF00849(PseudoU_synth_2) | 4 | ASP A 17SER A 15CYH A 89ASP A 218 | None | 0.97A | 3m0wE-5vbbA:undetectable3m0wF-5vbbA:undetectable3m0wG-5vbbA:undetectable3m0wH-5vbbA:undetectable | 3m0wE-5vbbA:14.563m0wF-5vbbA:14.563m0wG-5vbbA:14.563m0wH-5vbbA:14.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w2m | DNA DC->DU-EDITINGENZYME APOBEC-3F (Homo sapiens) |
no annotation | 4 | PHE A 336PHE A 302LEU A 364ASP A 365 | None | 0.95A | 3m0wE-5w2mA:undetectable3m0wF-5w2mA:undetectable3m0wG-5w2mA:undetectable3m0wH-5w2mA:undetectable | 3m0wE-5w2mA:26.673m0wF-5w2mA:26.673m0wG-5w2mA:26.673m0wH-5w2mA:26.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x49 | PROBABLE XAA-PROAMINOPEPTIDASE 3 (Homo sapiens) |
PF00557(Peptidase_M24)PF05195(AMP_N) | 4 | ASP A 477PHE A 266CYH A 290LEU A 298 | None | 0.93A | 3m0wE-5x49A:undetectable3m0wF-5x49A:undetectable3m0wG-5x49A:undetectable3m0wH-5x49A:undetectable | 3m0wE-5x49A:13.773m0wF-5x49A:13.773m0wG-5x49A:13.773m0wH-5x49A:13.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xh9 | EXTRACELLULARINVERTASE (Aspergilluskawachii) |
PF00251(Glyco_hydro_32N)PF08244(Glyco_hydro_32C) | 4 | SER A 277PHE A 198LEU A 207ASP A 204 | None | 1.01A | 3m0wE-5xh9A:undetectable3m0wF-5xh9A:undetectable3m0wG-5xh9A:undetectable3m0wH-5xh9A:undetectable | 3m0wE-5xh9A:9.733m0wF-5xh9A:9.733m0wG-5xh9A:9.733m0wH-5xh9A:9.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xtc | NADH DEHYDROGENASE[UBIQUINONE] 1 ALPHASUBCOMPLEX SUBUNIT11 (Homo sapiens) |
no annotation | 4 | ASP V 11SER V 24CYH V 75ASP V 17 | None | 0.92A | 3m0wE-5xtcV:undetectable3m0wF-5xtcV:undetectable3m0wG-5xtcV:undetectable3m0wH-5xtcV:undetectable | 3m0wE-5xtcV:19.313m0wF-5xtcV:19.313m0wG-5xtcV:19.313m0wH-5xtcV:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y0q | UPF0348 PROTEINB4417_3650 (Bacillussubtilis) |
no annotation | 4 | SER A 240PHE A 393SER A 51LEU A 338 | None | 1.02A | 3m0wE-5y0qA:undetectable3m0wF-5y0qA:undetectable3m0wG-5y0qA:undetectable3m0wH-5y0qA:undetectable | 3m0wE-5y0qA:undetectable3m0wF-5y0qA:undetectable3m0wG-5y0qA:undetectable3m0wH-5y0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y3r | X-RAY REPAIRCROSS-COMPLEMENTINGPROTEIN 5 (Homo sapiens) |
PF02735(Ku)PF03730(Ku_C)PF03731(Ku_N) | 4 | ASP B 72SER B 145LEU B 111ASP B 109 | None | 0.91A | 3m0wE-5y3rB:undetectable3m0wF-5y3rB:undetectable3m0wG-5y3rB:undetectable3m0wH-5y3rB:undetectable | 3m0wE-5y3rB:11.453m0wF-5y3rB:11.453m0wG-5y3rB:11.453m0wH-5y3rB:11.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yid | PLASMEPSIN II (Plasmodiumfalciparum) |
no annotation | 4 | ASP A 305PHE A 315LEU A 126ASP A 36 | NoneNoneNoneK95 A 401 ( 2.6A) | 1.06A | 3m0wE-5yidA:undetectable3m0wF-5yidA:undetectable3m0wG-5yidA:undetectable3m0wH-5yidA:undetectable | 3m0wE-5yidA:15.893m0wF-5yidA:15.893m0wG-5yidA:15.893m0wH-5yidA:15.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bhu | MULTIDRUGRESISTANCE-ASSOCIATED PROTEIN 1 (Bos taurus) |
no annotation | 4 | ASP A1080SER A 612LEU A 437ASP A 436 | None | 0.83A | 3m0wE-6bhuA:0.63m0wF-6bhuA:undetectable3m0wG-6bhuA:0.03m0wH-6bhuA:undetectable | 3m0wE-6bhuA:0.003m0wF-6bhuA:0.003m0wG-6bhuA:0.003m0wH-6bhuA:0.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c1d | UNCONVENTIONALMYOSIN-IB (Rattusnorvegicus) |
no annotation | 4 | ASP P 461PHE P 475CYH P 483LEU P 448 | None | 0.96A | 3m0wE-6c1dP:undetectable3m0wF-6c1dP:undetectable3m0wG-6c1dP:undetectable3m0wH-6c1dP:0.6 | 3m0wE-6c1dP:19.823m0wF-6c1dP:19.823m0wG-6c1dP:19.823m0wH-6c1dP:19.82 |